Neurent Medical
Neurent Medical develops NEUROMARK, a minimally invasive radiofrequency treatment for chronic rhinitis.
$25MGrowth investment
ParticipantCC
Claret Capital Partners
Activity from announced rounds
Activity in this selectionOct 24, 2026 · Healthtech · Jan 1, 2026
- Rounds participated in
- 1
- Confirmed lead rounds
- 0 All roles disclosed
- New companies
- 1 First participation on record · 0 follow-on
- Funding in participating rounds
- $25M 1 disclosed · full round size, not this investor’s share